Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ARTL

Artelo Biosciences (ARTL)

Artelo Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARTL
DateTimeSourceHeadlineSymbolCompany
23/04/202422:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer TherapyNASDAQ:ARTLArtelo Biosciences Inc
22/04/202422:30GlobeNewswire Inc.Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern TimeNASDAQ:ARTLArtelo Biosciences Inc
25/03/202423:00GlobeNewswire Inc.Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
13/03/202400:15GlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNASDAQ:ARTLArtelo Biosciences Inc
24/01/202400:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral NeuropathyNASDAQ:ARTLArtelo Biosciences Inc
09/01/202400:30GlobeNewswire Inc.Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12NASDAQ:ARTLArtelo Biosciences Inc
06/12/202300:30GlobeNewswire Inc.Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
01/12/202301:00GlobeNewswire Inc.Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
14/11/202300:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
14/11/202300:00GlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
10/11/202301:00GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain CancersNASDAQ:ARTLArtelo Biosciences Inc
02/11/202323:30GlobeNewswire Inc.Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023NASDAQ:ARTLArtelo Biosciences Inc
04/10/202323:30GlobeNewswire Inc.Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and CachexiaNASDAQ:ARTLArtelo Biosciences Inc
13/09/202322:30GlobeNewswire Inc.Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20thNASDAQ:ARTLArtelo Biosciences Inc
07/09/202322:00GlobeNewswire Inc.Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12NASDAQ:ARTLArtelo Biosciences Inc
06/09/202323:00GlobeNewswire Inc.Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12thNASDAQ:ARTLArtelo Biosciences Inc
05/09/202323:00GlobeNewswire Inc.Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13thNASDAQ:ARTLArtelo Biosciences Inc
10/08/202322:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
10/08/202322:00GlobeNewswire Inc.Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
09/08/202306:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLArtelo Biosciences Inc
09/08/202306:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLArtelo Biosciences Inc
19/07/202323:00GlobeNewswire Inc.Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023NASDAQ:ARTLArtelo Biosciences Inc
17/07/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ARTLArtelo Biosciences Inc
10/07/202322:30GlobeNewswire Inc.Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11NASDAQ:ARTLArtelo Biosciences Inc
07/07/202322:23Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:ARTLArtelo Biosciences Inc
07/07/202306:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ARTLArtelo Biosciences Inc
04/07/202304:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLArtelo Biosciences Inc
04/07/202304:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLArtelo Biosciences Inc
28/06/202322:30GlobeNewswire Inc.Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
27/06/202322:30GlobeNewswire Inc.Artelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ARTL